Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are calcium antagonists proarrhythmic?

A L Bassett, S Chakko, M Epstein

    Journal of Hypertension
    |October 10, 1997
    PubMed
    Summary
    This summary is machine-generated.

    Calcium antagonists can prevent arrhythmias but may paradoxically cause them. Certain conditions, like blood pressure drops, can lead to calcium overload and heart rhythm issues, especially in diseased hearts.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Visible-spectroscopy study of the adsorption of alizarinate by Al-montmorillonite in aqueous suspensions and in solid state.

    Journal of colloid and interface science·2003
    Same author

    Evolving therapeutic strategies for retarding progression of diabetic nephropathy--an update for 2002.

    Acta diabetologica·2002
    Same author

    Importance of potassium in cardiovascular disease.

    Journal of clinical hypertension (Greenwich, Conn.)·2002
    Same author

    Lercanidipine: a novel dihydropyridine calcium-channel blocker.

    Heart disease (Hagerstown, Md.)·2002
    Same author

    Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.

    Journal of human hypertension·2002
    Same author

    Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2001

    Area of Science:

    • Cardiology
    • Pharmacology
    • Electrophysiology

    Background:

    • Myocardial calcium (Ca2+) overload is linked to serious arrhythmias.
    • Calcium antagonists reduce Ca2+ entry into heart cells, with verapamil and diltiazem treating supraventricular arrhythmias.
    • Dihydropyridine (DHP) calcium antagonists show promise in preventing ventricular arrhythmias in laboratory settings.

    Discussion:

    • A controversy exists regarding the safety of some calcium antagonists, particularly in coronary heart disease patients, due to potential proarrhythmia.
    • While high doses of verapamil/diltiazem can cause conduction blocks, direct links to ventricular tachyarrhythmias are limited.
    • Paradoxically, calcium antagonists can induce myocardial Ca2+ overload under specific conditions, such as neurohormonal activation from blood pressure reduction.

    Related Experiment Videos

    Key Insights:

    • Beta-adrenergic stimulation during neurohormonal activation may enhance Ca2+ influx via L-type channels, potentially causing overload and arrhythmias, especially in compromised hearts.
    • The article examines interactions between cardiac calcium channels, antagonist classes, and formulations regarding direct ventricular arrhythmogenesis.
    • Indirect proarrhythmic effects of calcium antagonists are also considered.

    Outlook:

    • Further research is needed to understand if beta-adrenergic stimulation influences DHP calcium antagonist efficacy on cardiac Ca2+ channels.
    • Clarifying the precise mechanisms of calcium antagonist-induced proarrhythmia is crucial for patient safety.
    • Investigating the role of specific drug formulations and patient conditions in calcium antagonist-related arrhythmias is essential.